378 results on '"Brodin E"'
Search Results
2. CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL
3. OP0058 CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONAL THERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STAR TRIAL
4. An Animal Model for the Study of Brain Transmittor Release in Response to Spinal Cord Stimulation in the Awake, Freely Moving Rat: Preliminary Results from the Periaqueductal Grey Matter
5. Comparison of ultrasound assisted catheter-directed thrombolysis (CDT) and CDT alone for treatment of proximal deep vein thrombosis: OR258
6. Regular physical activity and future risk of myocardial infarction and venous thrombosis - the tromsø study: OR075
7. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment
8. A Substance P Antagonist Inhibits Vagally Induced Increase in Vascular Permeability and Bronchial Smooth Muscle Contraction in the Guinea Pig
9. Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Tromsø study
10. Impact of different measures of renal impairment on future risk of venous thromboembolism. The Tromsø study: PB 2.70–3
11. Thyroid function, assessed by thyroid stimulating hormone, and future risk of venous thromboembolism -the Tromsø study: PB 1.70–1
12. Seasonal variation of venous thrombosis: a consecutive case series within studies from Leiden, Milan and Tromsφ
13. Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsφ study
14. The Swedish version of the Haemophilia Activity List
15. OP0018 A MULTICENTER RANDOMIZED STUDY IN EARLY RHEUMATOID ARTHRITIS TO COMPARE ACTIVE CONVENTIONAL THERAPY VERSUS THREE BIOLOGICAL TREATMENTS: 24 WEEK EFFICACY RESULTS OF THE NORD-STAR TRIAL
16. Session S2.3: The Swedish haemophiliacʼs self reported activity and function in daily life: reported with HAL, AIMS 2, and IPA: 27FP09
17. Analysis of a diary written by a woman with acquired haemophilia A postpartum, in a narrative approach - a case report: 30P39
18. Elimination of human recombinant mammalian tissue factor pathway inhibitor in a rat model: OC-MO-058
19. Simultaneous determination of cholecystokinin, dopamine, glutamate and aspartate in cortex and striatum of the rat using in vivo microdialysis
20. PS1482 EFFECT OF THROMBOPOIETIN RECEPTOR AGONISTS (TPO-RAS) ON ENDOTHELIAL CELLS AND NEUTROPHIL EXTRACELLULAR TRAP (NET) FORMATION IN IMMUNE THROMBOCYTOPENIA (ITP)
21. Spinal expression of mRNA for immediate early genes in a model of chronic pain
22. Temporal changes in spinal cord expression of mRNA for substance P, dynorphin and enkephalin in a model of chronic pain
23. No release of histamine and substance P in capsaicin-induced neurogenic inflammation in intact human skin in vivo: a microdialysis study
24. NO RELEASE OF HISTAMINE OR SUBSTANCE IN CAPSAICIN-INDUCED NEUROGENIC INFLAMMATION IN INTACT HUMAN SKIN IN VIVO : 308
25. Chapter 28 Restoration of function to the denervated spinal cord after implantation of embryonic 5HT- and substance P-containing raphe neurones
26. Self-reported activity of Swedish persons with haemophilia: Change over 2.5 years
27. The european hematology association roadmap for european hematology research: A consensus document
28. The European Hematology Association Roadmap for European Hematology Research: a consensus document.
29. The european hematology association roadmap for european hematology research: A consensus document
30. Striato-Nigral Tachykinin Neurons and Influence from Striatal Dopamine and GABA
31. Neuropeptide Y, enkephalin and noradrenaline coexist in sympathetic neurons innervating the bovine spleen: Biochemical and immunohistochemical evidence
32. Peptide-containing neurons intrinsic to the gut wall: An experimental study in the pig
33. Primary sensory neurons of the rat showing calcitonin gene-related peptide immunoreactivity and their relation to substance P-, somatostatin-, galanin-, vasoactive intestinal polypeptide- and cholecystokinin-immunoreactive ganglion cells
34. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation
35. Calcitonin gene-related peptide-like immunoreactivity in nerve fibers in the human skin: Relation to fibers containing substance P-, somatostatin- and vasocactive intestinalpolypeptide-like immunoreactivity
36. Immunohistochemical and behavioral analysis of spinal lesions induced by a substance P antagonist and protection by thyrotropin releasing hormone
37. Abstracts
38. Immunoreactive substance P in the chicken gut: Distribution, development and possible functional significance
39. Modelling, estimation and visualization of multivariate dependence for high-frequency data
40. Extreme value theory in finance
41. IMMUNOHISTOCHEMICAL LOCALIZATION OF SUBSTANCE P IN MOUSE GUT
42. Localization of substance P-like immunoreactivity in mouse gut
43. Neurokinin A-like immunoreactivity in rat primary sensory neurons; coexistence with substance P
44. Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function - the Tromso study
45. F104 RESOLVINS AND LIPOXINS ATTENUATE CARRAGEENAN-INDUCED INFLAMMATORY PAIN
46. Spinal Astrocytes in Pain Processing: Non-Neuronal Cells as Therapeutic Targets
47. Pharmacology — a historical overview
48. Local administration of morphine decreases the extracellular level of GABA in the periaqueductal gray matter of freely moving rats.
49. Commentary. The employment status of ministers of religion
50. Effects of acute systemic treatment with the 5 HT-uptake blocker alaproclate on tissue levels and release of substance P in rat periaqueductal grey
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.